WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 12,58 | 12,58 | 2019-09-30 |
| Nordnet Pensionsförsäkring | 10,25 | 10,25 | 2019-09-30 |
| Kjell Stenberg | 5,97 | 5,97 | 2019-09-30 |
| Tommy Andersson | 4,24 | 4,24 | 2019-09-30 |
| Lars-Erik Forsgårdh | 2,14 | 2,14 | 2019-09-30 |
| Leif Bertils | 1,13 | 1,13 | 2019-09-30 |
| Nils Qvarner | 1,10 | 1,10 | 2019-09-30 |
| Bostadsrättsbyggarna Svenska Holding AB | 0,93 | 0,93 | 2019-09-30 |
| Swedbank Försäkring | 0,73 | 0,73 | 2019-09-30 |
| Livförsäkringsbolaget Skandia | 0,65 | 0,65 | 2019-09-30 |
2019-11-14 Delårsrapport 2019-Q3
2020-02-20 Bokslutskommuniké 2019